‘Everything Goes to Tripoli and for the South, There’s Nothing’. EU Migration Externalization and Grievances in a Marginalized Southern Libya
Progress in Development Studies · 06.07.2026
DOI: 10.1177/14649934261461049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Progress in Development Studies, online erschienen am 06.07.2026. Verfasst von Hans Lucht und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
This article examines how European Union (EU) migration externalization is perceived and negotiated in southern Libya. Drawing on fieldwork conducted in 2022–2023 in Kufra and across the Fezzan, it analyses how geographically concentrated migration cooperation shapes grievances, governance and political dynamics. While EU engagement prioritizes coastal institutions, southern actors describe themselves as the ‘frontline’ of irregular migration, yet are excluded from decision-making arenas. Externalization operates within a hybrid conflict economy where control over mobility generates revenue and leverage and intersects with regional and racial marginalization. The article highlights the intra-state ‘rippling effects’ of migration externalization.
Zitieren
APA
Lucht, H., & Lndi, A. (2026). ‘Everything Goes to Tripoli and for the South, There’s Nothing’. EU Migration Externalization and Grievances in a Marginalized Southern Libya. Progress in Development Studies. https://doi.org/10.1177/14649934261461049
Vancouver
Lucht H, Lndi A. ‘Everything Goes to Tripoli and for the South, There’s Nothing’. EU Migration Externalization and Grievances in a Marginalized Southern Libya. Progress in Development Studies. 2026. doi:10.1177/14649934261461049
BibTeX
@article{Lucht2026,
author = {Lucht, Hans and Lndi, Abubaker},
title = {‘Everything Goes to Tripoli and for the South, There’s Nothing’. EU Migration Externalization and Grievances in a Marginalized Southern Libya},
journal = {Progress in Development Studies},
year = {2026},
doi = {10.1177/14649934261461049}
}
EUVIMED